BMCS BioTech Medics Inc (PK)

BioTech Medics, Inc. (PINKSHEETS: BMCS), a 10-year-old company, announced that it is initiating the design of a fleet of Mobile Pain Management Vehicles. The Units are part of its negotiations with one of the nation's premier franchise consulting firms that specializes in developing innovative new leading concepts such as the existing four operating BioTech L3aser(TM) Pain Management & Wellness Centers.

BioTech has developed proprietary pain management protocols utilizing FDA 510(k) cleared high powered deep penetrating medical therapeutic lasers for reducing or eliminating muscular, skeletal, nerve and/or arthritic pain over the entire body. The procedures are drug-free, quick (15 to 30 minutes), safe and non-invasive. BioTech has affiliated centers operating in Dallas, Kansas City (Overland Park), Albuquerque and Santa Fe, NM.

Each Mobile Unit could generate up to $810,000 in Annual Revenue. The Mobile Units will have a licensed pain management practitioner and certified laser technicians. The Unit can be driven to large office complexes, shopping malls, manufacturing plants and sporting events providing relief to scores of staff, employees, athletes and sports fans on location.

Keith Houser, Chairman and CEO of BioTech, stated, "These Mobile Units eliminate drive times and waiting periods experienced if thousands of persons were to visit medical facilities for treatment. The Units are designed with the intent of saving downtime for the millions of Americans that experience back, hip, shoulder and knee pain as well as 90 other ailments such as carpel tunnel syndrome."

Houser stated: "Our goal has been to have 100 or more BioTech L3aser(TM) Centers operating nationwide, similar to the 80 Lasik-Plus Eye Vision Centers operating today. The franchise alliance will put BioTech on fast-track to accomplish our goals. The Mobile Units allow us to capture patients that might otherwise procrastinate or question the validity of this proven treatment. Plus, it is designed to increase our sales to patients who have not been exposed to the cost effective benefits of laser technology."

By offering franchises BioTech will receive a franchise fee, revenue from 1) the sale of medical lasers, 2) training of staff fees, 3) monthly protocol/royalty fees and 4) sales from SHBAN(TM) / BioBody(TM) products. Franchise Registration with each state regulatory agency is required. There should not be any equity dilution as a result of the franchise agreement.

BioTech's advantage over competition is the proprietary protocols for the high-powered therapeutic medical lasers. The patient feels the laser healing their body. Most competitors use "cold lasers" that operate with less power. Patients cannot feel a cold laser.

Safe Harbor for Forward-Looking Statements.

This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). Such statements are subject to risks, uncertainties and actual results could differ materially from those expressed in any of the statements. This is not an offer to buy or sell any security or franchise.

Contact: Investor Relations 972-274-5533